Bell Potter upgraded Life Healthcare to a "buy" from a "hold" and has a price target of $3.57 on the stock.
"The company has not provided earnings guidance for FY16, however, the business continues to experience strong organic sales growth including new product launches and further additions to its sales force.
Loading...
Elise Shaw writes on Markets specialising in Equity Markets, Commodities, Mining. Based in our Sydney newsroom, Elise has over 25 years experience as a finance and markets journalist and editor. Connect with Elise on Twitter.
